MedAxiom Announces Industry Partnership with Novocardia

Partner News | Published: Monday, September 13, 2021

MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, is proud to announce its industry partnership with Novocardia, a value-based cardiovascular disease care delivery platform.

“Novocardia and MedAxiom share a dedication to helping cardiologists and their practices navigate the everchanging healthcare landscape while increasing access to physician-led, patient-centered cardiovascular care,” said Joe Sasson, PhD, MedAxiom’s executive vice president of Ventures. “We’re thrilled to partner with the Novocardia team and look forward to the expertise they will bring to the MedAxiom community.”

Founded in 2020 by two cardiologists – Dan Blumenthal, MD, MBA, and Julius Torelli, MD, FACC – Novocardia helps cardiologists prepare for challenges now and in the future. Over the last decade, cardiologists have witnessed extreme shifts in the healthcare landscape including new employment models, changes in reimbursement and increased reporting requirements. As these changes continue to accelerate, Novocardia’s mission is to provide resources and expertise to successfully deliver the highest quality care to cardiovascular patients.

"Our partnership with MedAxiom will enable Novocardia to further refine our unique position in helping cardiovascular disease clinicians and their practices navigate changes in the healthcare industry," said Dr. Blumenthal, Chief Executive Officer of Novocardia. "As transformation continues to accelerate, we can provide clinicians with the expertise and resources to best traverse changes in the reimbursement landscape and to succeed under payment and delivery models which emphasize value over volume." 

Learn more about Novocardia at

About MedAxiom

MedAxiom, an ACC Company, is the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of 425+ cardiovascular organization members, thousands of administrators, clinicians and coders and 35+ industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. For additional information, visit

About Novocardia™

Founded in 2020, Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States and help patients with heart and vascular disease live longer, healthier and more satisfying lives. We are committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care. To learn more about Novocardia, please visit



This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.